{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:21:04Z","timestamp":1790176864326,"version":"4.1.0"},"reference-count":23,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,12,25]],"date-time":"2019-12-25T00:00:00Z","timestamp":1577232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81430060"],"award-info":[{"award-number":["81430060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>K-ras (Kirsten ras GTPase) mutations are oncogenic events frequently observed in many cancer types especially in pancreatic cancer. Although mitochondrial dysfunction has been associated with K-ras mutation, the molecular mechanisms by which K-ras impacts mitochondria and maintains metabolic homeostasis are not fully understood. In this study, we used two K-ras inducible cell systems, human pancreatic epithelial\/ K-rasG12D (HPNE\/K-rasG12D) and human embryonic kidney cells with tetracycline repressorT-Rex\/K-rasG12V, to evaluate the role of oncogenic K-ras in regulating mitochondrial function. Among a panel of genes known to affect mitochondria, only the expression of OPA3 (optic atrophy protein 3) was consistently up-regulated by K-ras activation in both cell lines. Importantly, high expression of OPA3 was also observed in clinical pancreatic cancer tissues. Genetic knockdown of OPA3 caused a significant decrease of energy metabolism, manifested by a suppression of oxygen consumption rate (OCR) and a decrease in cellular ATP content, leading to inhibition of cell proliferation capacity and reduced expression of epithelial\u2013mesenchymal transition (EMT) markers. Our study suggests that OPA3 may promote cellular energy metabolism and its up-regulation in K-ras-driven cancer is likely a mechanism to offset the negative impact of K-ras on mitochondria to maintain energy homeostasis. As such, OPA3 could be a potential target to kill cancer cells with K-ras mutations.<\/jats:p>","DOI":"10.3390\/cancers12010065","type":"journal-article","created":{"date-parts":[[2019,12,25]],"date-time":"2019-12-25T11:07:48Z","timestamp":1577272068000},"page":"65","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Oncogenic K-ras Induces Mitochondrial OPA3 Expression to Promote Energy Metabolism in Pancreatic Cancer Cells"],"prefix":"10.3390","volume":"12","author":[{"given":"Ning","family":"Meng","sequence":"first","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1944-611X","authenticated-orcid":false,"given":"Christophe","family":"Glorieux","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Liang","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiting","family":"Zeng","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Lu","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China"},{"name":"Metabolic Innovation Center, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc949","article-title":"Pancreatic cancer biology and genetics","volume":"2","author":"Bardeesy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","first-page":"4682","article-title":"Ras oncogenes in human cancer: A review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer","volume":"359","author":"Herbst","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.4161\/cc.7.17.6596","article-title":"Mechanisms of Ras membrane organization and signalling: Ras on a rocker","volume":"7","author":"Abankwa","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1158\/0008-5472.CAN-03-3909","article-title":"The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation","volume":"64","author":"Mitsushita","year":"2004","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2011.145","article-title":"K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis","volume":"22","author":"Hu","year":"2012","journal-title":"Cell Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"14437","DOI":"10.1038\/ncomms14437","article-title":"Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma","volume":"8","author":"Ju","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.18632\/oncotarget.2968","article-title":"Identification of NDUFAF1 in mediating K-Ras induced mitochondrial dysfunction by a proteomic screening approach","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/15548627.2018.1450708","article-title":"Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis","volume":"14","author":"Lin","year":"2018","journal-title":"Autophagy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.celrep.2019.07.031","article-title":"Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth","volume":"28","author":"Nagdas","year":"2019","journal-title":"Cell Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/onc.2012.50","article-title":"Oncogenic K-ras expression is associated with derangement of the cAMP\/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration","volume":"32","author":"Palorini","year":"2013","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and Cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s00018-010-0365-z","article-title":"Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation","volume":"67","author":"Ryu","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.molcel.2015.01.002","article-title":"Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth","volume":"57","author":"Kashatus","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molcel.2015.01.003","article-title":"Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors","volume":"57","author":"Serasinghe","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tcb.2013.05.004","article-title":"Metabolism in physiological cell proliferation and differentiation","volume":"23","author":"Agathocleous","year":"2013","journal-title":"Trends Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fonc.2013.00292","article-title":"Mitochondrial dysfunction in cancer","volume":"3","author":"Boland","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbabio.2009.11.006","article-title":"Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells","volume":"1797","author":"Baracca","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fphys.2012.00362","article-title":"Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling","volume":"3","author":"Alberghina","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1101\/gad.219642.113","article-title":"Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis","volume":"27","author":"Guo","year":"2013","journal-title":"Genes Dev."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ryu, S.W., Yoon, J., Yim, N., Choi, K., and Choi, C. (2013). Downregulation of OPA3 is responsible for transforming growth factor-beta-induced mitochondrial elongation and F-actin rearrangement in retinal pigment epithelial ARPE-19 cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063495"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.freeradbiomed.2016.08.031","article-title":"Chromatin remodeling regulates catalase expression during cancer cells adaptation to chronic oxidative stress","volume":"99","author":"Glorieux","year":"2016","journal-title":"Free Radic. Biol. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/65\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:45:28Z","timestamp":1760190328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["cancers12010065"],"URL":"https:\/\/doi.org\/10.3390\/cancers12010065","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,25]]}}}